Efficiency and quality are paramount in accelerating trial launches. At CenExel, streamlined processes and rigorous standards ensure swift start-ups. This commitment to excellence expedites the journey towards groundbreaking clinical research discoveries! For more information, visit www.CenExel.com! #Cenexel #ClinicalTrials #ExpediteTrials
CenExel’s Post
More Relevant Posts
-
Efficiency and quality are paramount in accelerating trial launches. At CenExel, streamlined processes and rigorous standards ensure swift start-ups. This commitment to excellence expedites the journey towards groundbreaking clinical research discoveries! For more information, visit www.CenExel.com! #CenExel #ClinicalTrials #ExpediteTrials
-
-
Smarter early phase decisions start with #CenExel. With decades of experience, we offer unparalleled expertise in early clinical research. From protocol design to execution, our comprehensive approach ensures robust data collection and analysis, empowering informed decisions. Trust CenExel to guide your path towards efficient drug development, reducing risks and accelerating timelines. Partner with us for a brilliant start to your research journey! To learn more --> www.cenexel.com #ClinicalTrials #EarlyPhase #ClinicalResearch
-
-
Early phase clinical trials are critical for assessing the safety, dosage, and efficacy of new treatments. CenExel supports these trials with its state-of-the-art facilities, experienced researchers, and robust infrastructure. By offering comprehensive services—from protocol design to data analysis—CenExel ensures the efficient and ethical conduct of trials, accelerating the development of innovative therapies! Want to know more? --> cenexel.com #CenExel #ClinicalResearch #ClinicalTrials
-
-
Early phase clinical trials are critical for assessing the safety, dosage, and efficacy of new treatments. CenExel supports these trials with its state-of-the-art facilities, experienced researchers, and robust infrastructure. By offering comprehensive services—from protocol design to data analysis—CenExel ensures the efficient and ethical conduct of trials, accelerating the development of innovative therapies! Want to know more? --> cenexel.com #CenExel #ClinicalResearch #ClinicalTrials
-
-
Will we see you there? Meet up with #RippleScience next week Wednesday to Friday in Philadelphia to understand how study teams recruit faster and engage better with Ripple! Hear from Pharma R&D, #FDA and #patientadvocacy on how patient involvement gets done to drive greater efficiencies in clinical research. #PatientsasPartners #patientengagement #tech #recruitmentsoftware #patientcentric #patientsaspartners2024 #clinicalresearchtech
-
-
🔍 Exploring the intricacies and essential service needs for cutting-edge biotechs seeking eCOA solutions. Dive into this insightful interview with Estelle Haenel & Adeline Meilhoc where their expertise illuminates the path through the dynamic challenges of our industry. 🚀 Discover a comprehensive view of eCOA's role in shaping the future of clinical research. Don't miss out! #eCOA #BiotechInnovation #ClinicalResearch
// Innovation and Partnerships: The Biotech Perspective // In this exclusive interview, Estelle Haenel, Chief Medical Officer at Kayentis, engages in a profound dialogue with Adeline Meilhoc, who leads Clinical Development at Acticor Biotech. Adeline offers a unique perspective, sharing valuable insights into the distinctive needs and challenges that small biotech firms like ACTICOR face when conducting clinical trials. From the intricacies of project-specific demands to the shifting dynamics within the industry, discover the in-depth insights provided by Adeline into the complexities and critical service requirements of innovative biotechs: https://bit.ly/48yqnnW #kayentis #eCOA #clinicaltrials #DCT #biotech
-
-
I'm thrilled to be part of this awesome webinar! Looking forward to sharing my experiences of working with small pharma and biotech teams, and witnessing their ability to adapt and leverage innovation successfully! See you all on May 20th! #clinicalresearch #smallpharmasuccess #biotechinnovation #smallbutmighty
👏🏽 Drumroll, please! We're excited to announce the first panelist for our upcoming webinar "De-Risking Innovation in Small Pharma and Biotech Clinical Research - Possible or Not?": Erika Talbott! 🎉 Erika, the Head of Customer and Site Success at Yonalink, comes to the clinical research world with fresh eyes and a fresh take, representing a very disruptive innovation in the EDC category. ⚡ 🔍 About the Webinar: Ever thought that innovation in clinical operations was only for big pharma with big budgets? Think again! Small pharma and biotech development groups are proving that innovation isn't just reserved for the giants. Join us on May 20 as we dive into this fascinating topic with insights from your peers! Register now 👉 https://lnkd.in/enx7-Nej Stay tuned as we unveil the next panelist next week! #ClinicalOperations #ClinicalResearch #ClinicalInnovation #ClinicalResearch #PharmaWebinar
-
-
Tufts Center for the Study of Drug Development has partnered with Digital Medicine Society (DiMe) on the DATAcc by DiMe’s new project, “Building the Business Case for Digital Endpoints." This project will increase investment in digital measurement development and deployment in clinical trials by developing a value framework, industry benchmarking tools, ROI forecasting models, and a modular template business case framework to support innovators across the field to invest in digital endpoints and advance their broad adoption and scale in clinical research. To learn more about this project, visit https://bit.ly/3VszB0D Tufts CSDD's Joseph DiMasi and Zachary Smith are continuing with an advisory role on the project and have collaborated with CSDD's Abigail Dirks, MS, Ken Getz, and other industry leaders at Johnson & Johnson, Roche, Genentech, UCB, Bayer, Takeda and MindMed on research "Assessing the Net Financial Benefits of Employing Digital Endpoints in Clinical Trials". To access the research article, visit https://bit.ly/3Vs8oex #digitalendpoints #clinicaltrials #research
-
-
Are you headed to BIO 2024? Be sure to connect with Todd Bertoch, MD, CEO of CenExel JBR and Carol Minoughan, Director of Business Development to learn more about how #CenExel can support your clinical trial needs! Want to know more about what our 18 Centers of Excellence can do? Check in here --> www.CenExel.com! #BIO2024 #ClinicalResearch #SanDiegoCA
-
-
SALES EXECUTIVE - BUSINESS DEVELOPMENT - RELATIONSHIP MANAGEMENT - OPERATIONS LEADERSHIP - ELEVATING BUSINESS PERFORMANCE - EXPEDITING GROWTH AND PROFITABILITY
We will be at the DPHARM: Disruptive Innovations to Modernize Clinical Research conference with our partners Hawthornehealth and Acclinate. Meet our experts, Talley Mitchell and Alice Cheng, to learn how we are driving innovation and making clinical trials more accessible and effective. To discuss how we can collaborate, schedule a meeting with Talley: Or schedule a meeting with Alice: #ClinicalTrials #DPHARMA2024
-
